3970 related articles for article (PubMed ID: 7054310)
1. Characterization of structural properties for morphological differentiation of melanosomes: II. Electron microscopic and SDS-PAGE comparison of melanosomal matrix proteins in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1982 Jan; 78(1):76-81. PubMed ID: 7054310
[TBL] [Abstract][Full Text] [Related]
2. Characterization of biochemical properties of melanosomes for structural and functional differentiation: analysis of the compositions of lipids and proteins in melanosomes and their subfractions.
Jimbow M; Kanoh H; Jimbow K
J Invest Dermatol; 1982 Aug; 79(2):97-102. PubMed ID: 7097043
[TBL] [Abstract][Full Text] [Related]
3. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
[TBL] [Abstract][Full Text] [Related]
4. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
[TBL] [Abstract][Full Text] [Related]
5. Characterization of structural properties for morphologic differentiation of melanosomes. III. free and protein-bound dopa and 5-S-cysteinyldopa in B16 and Harding-Passey melanomas.
Ito S; Homma K; Kiyota M; Fujita K; Jimbow K
J Invest Dermatol; 1983 Mar; 80(3):207-9. PubMed ID: 6402551
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonic measurement of melanosomes for characterization of their physicochemical structure in B16 and Harding-Passey melanomas.
Kono R; Jimbow K; Takahashi H; Maeda K
Cancer Res; 1984 Oct; 44(10):4337-41. PubMed ID: 6467195
[TBL] [Abstract][Full Text] [Related]
7. Atypical melanosomal proteins in human malignant melanoma.
Klingler WG; Montague PM; Chretien PB; Hearing VJ
Arch Dermatol; 1977 Jan; 113(1):19-23. PubMed ID: 831619
[TBL] [Abstract][Full Text] [Related]
8. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.
Jimbow K; Horikoshi T; Takahashi H; Akutsu Y; Maeda K
J Invest Dermatol; 1989 May; 92(5 Suppl):304S-309S. PubMed ID: 2715663
[TBL] [Abstract][Full Text] [Related]
9. Transfer of tyrosinase to melanosomes in Harding-Passey mouse melanoma.
Tomita Y; Hariu A; Kato C; Seiji M
Arch Biochem Biophys; 1983 Aug; 225(1):75-85. PubMed ID: 6412634
[TBL] [Abstract][Full Text] [Related]
10. Human malignant melanoma. Melanosomal polymorphism and the ultrastructural dopa reaction.
Hunter JA; Paterson WD; Fairley DJ
Br J Dermatol; 1978 Apr; 98(4):381-90. PubMed ID: 638044
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the amino acid composition of some tumor and normal melanosomes.
Borovanský J; Duchon J
Neoplasma; 1975; 22(2):195-9. PubMed ID: 1161115
[TBL] [Abstract][Full Text] [Related]
12. Cellular fine structure in the invasive nodules of different histogenetic types of malignant melanoma.
Hunter JA; Zaynoun S; Paterson WD; Bleehen SS; Mackie R; Cochran AJ
Br J Dermatol; 1978 Mar; 98(3):255-72. PubMed ID: 638037
[TBL] [Abstract][Full Text] [Related]
13. Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation.
Rhodes AR; Seki Y; Fitzpatrick TB; Stern RS
Cancer; 1988 Jan; 61(2):358-69. PubMed ID: 3334971
[TBL] [Abstract][Full Text] [Related]
14. Fine structural characterization of melanosomes in dysplastic nevi.
Takahashi H; Horikoshi T; Jimbow K
Cancer; 1985 Jul; 56(1):111-23. PubMed ID: 4005780
[TBL] [Abstract][Full Text] [Related]
15. Identification of rab7 as a melanosome-associated protein involved in the intracellular transport of tyrosinase-related protein 1.
Gomez PF; Luo D; Hirosaki K; Shinoda K; Yamashita T; Suzuki J; Otsu K; Ishikawa K; Jimbow K
J Invest Dermatol; 2001 Jul; 117(1):81-90. PubMed ID: 11442753
[TBL] [Abstract][Full Text] [Related]
16. Nature and biosynthesis of structural matrix protein in melanosomes: melanosomal structural protein as differentiation antigen for neoplastic melanocytes.
Jimbow K; Yamana K; Akutsu Y; Maeda K
Prog Clin Biol Res; 1988; 256():169-82. PubMed ID: 3368488
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopic evidence for stimulation of melanosomal maturation by lysosomotropic agents and monensin in cultured B16 mouse melanoma cells.
Oikawa A; Saeki H; Akiyama T; Matsumoto J
Pigment Cell Res; 1987; 1(1):44-50. PubMed ID: 3507662
[TBL] [Abstract][Full Text] [Related]
18. Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas.
Chen KG; Valencia JC; Lai B; Zhang G; Paterson JK; Rouzaud F; Berens W; Wincovitch SM; Garfield SH; Leapman RD; Hearing VJ; Gottesman MM
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9903-7. PubMed ID: 16777967
[TBL] [Abstract][Full Text] [Related]
19. Uptake of melanosomes and increased melanin formation by cultured melanoma cells after treatment with isolated melanosomes.
Schachtschabel DO; Leising HB; Schjeide OA; Molsen DV
Cytobios; 1978; 21(81):23-36. PubMed ID: 751776
[TBL] [Abstract][Full Text] [Related]
20. Distribution of 65Zn in mice with melanomas and in the subcellular fractions of melanomas.
Borovanský J; Hearn PR; Bleehen SS; Russell RG
Neoplasma; 1980; 27(3):247-52. PubMed ID: 7453844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
